Evidence for a central role for PfCRT in conferring Plasmodium falciparum resistance to diverse antimalarial agents

Molecular Cell
David J JohnsonStephen A Ward

Abstract

Chloroquine resistance in Plasmodium falciparum is primarily conferred by mutations in pfcrt. Parasites resistant to chloroquine can display hypersensitivity to other antimalarials; however, the patterns of crossresistance are complex, and the genetic basis has remained elusive. We show that stepwise selection for resistance to amantadine or halofantrine produced previously unknown pfcrt mutations (including S163R), which were associated with a loss of verapamil-reversible chloroquine resistance. This was accompanied by restoration of efficient chloroquine binding to hematin in these selected lines. This S163R mutation provides insight into a mechanism by which PfCRT could gate the transport of protonated chloroquine through the digestive vacuole membrane. Evidence for the presence of this mutation in a Southeast Asian isolate supports the argument for a broad role for PfCRT in determining levels of susceptibility to structurally diverse antimalarials.

References

Dec 1, 1979·Antimicrobial Agents and Chemotherapy·R E DesjardinsJ D Chulay
Aug 20, 1976·Science·W Trager, J B Jensen
Jan 1, 1992·Transactions of the Royal Society of Tropical Medicine and Hygiene·L K BascoJ Le Bras
May 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·A YayonH Ginsburg
Nov 1, 1994·Transactions of the Royal Society of Tropical Medicine and Hygiene·S G Evans, I Havlik
Nov 1, 1993·Antimicrobial Agents and Chemotherapy·M NateghpourR E Howells
Feb 1, 1994·Proceedings of the National Academy of Sciences of the United States of America·A F CowmanJ K Thompson
Mar 1, 1997·European Journal of Biochemistry·R P MoonR G Ridley
Oct 6, 1997·Proceedings of the National Academy of Sciences of the United States of America·D A Fidock, T E Wellems
Sep 16, 2000·Molecular and Biochemical Parasitology·S M DzekunovP D Roepe
Feb 15, 2001·The New England Journal of Medicine·D C Warhurst
May 18, 2001·Molecular and Biochemical Parasitology·R DurandJ Le Bras
Jun 8, 2001·Parasitology·S Paget-McNicol, A Saul
Oct 25, 2001·Proceedings of the National Academy of Sciences of the United States of America·R K MehlotraP A Zimmerman
Nov 13, 2001·Tropical Medicine & International Health : TM & IH·U D'Alessandro, H Buttiëns
Sep 28, 2002·The Journal of Biological Chemistry·Hanbang ZhangPaul D Roepe
Dec 25, 2002·Antimicrobial Agents and Chemotherapy·Pharath LimThierry Fandeur
Apr 12, 2003·Science·Deirdre A JoyXin-zhuan Su
Sep 16, 2003·FEBS Letters·Marie L KellyLawrence H Pinto
Nov 25, 2003·The Journal of Biological Chemistry·Richard J W Allen, Kiaran Kirk
Dec 12, 2003·Molecular and Biochemical Parasitology·Tyler N BennettPaul D Roepe
Mar 1, 1992·Parasitology Today·F J Ayala, W M Fitch

❮ Previous
Next ❯

Citations

Feb 26, 2013·Chemical Reviews·Lukas WankaPeter R Schreiner
Mar 23, 2012·Journal of Medicinal Chemistry·Yiqun ZhangR Kiplin Guy
Nov 2, 2004·Nature Medicine·Thomas E Wellems
Feb 1, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Gabriella A FarcasKevin C Kain
Dec 22, 2012·Antioxidants & Redox Signaling·Eva-Maria PatzewitzSylke Müller
Jan 16, 2008·Antimicrobial Agents and Chemotherapy·David J JohnsonStephen A Ward
Feb 4, 2009·Antimicrobial Agents and Chemotherapy·Sant MuangnoicharoenStephen A Ward
Apr 15, 2009·Antimicrobial Agents and Chemotherapy·Victor MassenoAlexis Nzila
Sep 5, 2006·Eukaryotic Cell·Godfrey LiskSanjay A Desai
Mar 6, 2012·BMC Genomics·Timothy G LilburnYufeng Wang
Dec 3, 2010·PloS One·Mauro ChinappiAnna Tramontano
Dec 16, 2010·Future Microbiology·Ingrid B Müller, John E Hyde
Apr 15, 2005·Emerging Infectious Diseases·Anthony S FauciGregory K Folkers
Aug 3, 2012·The American Journal of Tropical Medicine and Hygiene·Rick M FairhurstArjen M Dondorp
Dec 18, 2014·International Journal for Parasitology. Drugs and Drug Resistance·Rebecca D SandlinDavid W Wright
Jan 31, 2012·Cellular and Molecular Life Sciences : CMLS·Robert L SummersRowena E Martin
May 12, 2005·Médecine sciences : M/S·Dominique Labie
Oct 2, 2012·Trends in Parasitology·Andrea EckerDavid A Fidock
Apr 20, 2010·International Journal for Parasitology·Cecilia P SanchezMichael Lanzer
Oct 27, 2006·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Donelly A van Schalkwyk, Timothy J Egan
Apr 9, 2005·Molecular Microbiology·Patrick G BrayDavid A Fidock
Sep 24, 2009·Tropical Medicine & International Health : TM & IH·G Q ZhangL H Tang
Oct 3, 2009·Molecular Microbiology·Rowena E MartinKiaran Kirk

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.